Document Detail


Determinants of sudden cardiac death in patients with persistent atrial fibrillation in the rate control versus electrical cardioversion (RACE) study.
MedLine Citation:
PMID:  16996876     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This report evaluated the correlates of sudden cardiac and nonsudden cardiac death in patients with persistent atrial fibrillation randomized to rate or rhythm control in the RAte Control vs Electrical cardioversion (RACE) study. Sudden cardiac death was observed in 16 patients, 8 patients in each group. Previous myocardial infarction resulted in a 4.9-fold increased risk of sudden death (95% confidence interval 1.8 to 13.2). The use of beta blockers showed their protective nature (hazard ratio 0.2, 95% confidence interval 0.05 to 0.9). The randomized treatment strategy, heart rhythm during follow-up, use of antiarrhythmic drugs, and number of stroke risk factors were not associated with sudden cardiac death. In conclusion, the treatment of underlying disease, rather than the heart rhythm, seems essential to prevent mortality.
Authors:
Vincent E Hagens; Michiel Rienstra; Dirk J Van Veldhuisen; Harry J G M Crijns; Isabelle C Van Gelder
Related Documents :
17036186 - Exercise and the risk of sudden cardiac death.
19841756 - Discovery of a symptomatic left anomalous coronary artery from the opposite sinus and p...
12613086 - Sudden cardiac death.
19387956 - The central nervous system and sudden cardiac death: what should we know?
7353256 - Alternate ventriculoatrial wenckebach conduction.
7921376 - Ginkgo biloba extract (egb 761) improves postischemic function in isolated precondition...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2006-08-11
Journal Detail:
Title:  The American journal of cardiology     Volume:  98     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2006 Oct 
Date Detail:
Created Date:  2006-09-25     Completed Date:  2006-11-09     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  929-32     Citation Subset:  AIM; IM    
Affiliation:
Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use
Aged
Amiodarone / therapeutic use
Anti-Arrhythmia Agents / therapeutic use*
Atrial Fibrillation / mortality,  therapy*
Calcium Channel Blockers / therapeutic use
Death, Sudden, Cardiac*
Diabetes Mellitus / epidemiology
Digitalis Glycosides / therapeutic use
Electric Countershock*
Fatigue / epidemiology
Female
Flecainide / therapeutic use
Follow-Up Studies
Humans
Male
Myocardial Infarction / epidemiology
Netherlands / epidemiology
Proportional Hazards Models
Recurrence / prevention & control
Risk Factors
Sotalol / therapeutic use
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Anti-Arrhythmia Agents; 0/Calcium Channel Blockers; 0/Digitalis Glycosides; 1951-25-3/Amiodarone; 3930-20-9/Sotalol; 54143-55-4/Flecainide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of mortality rates in statin users versus nonstatin users in a United States veteran popu...
Next Document:  Distribution and prognostic significance of QT intervals in the lowest half centile in 12,012 appare...